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HIV-1 infection leads to death of CD41 T cells in vivo and in vitro, although the mechanisms of this cell death are not well
defined. We used flow cytometry to concurrently analyze infection and apoptosis of the CD41 CEM T cell line and human
peripheral blood mononuclear cells (PBMC). Surprisingly, T cells productively infected with HIV-1 IIIB showed less apoptosis
than control, uninfected T cells. This relative paucity of apoptosis was a characteristic of IIIB, since a large number of cells
infected with the viral clone, HIV-1 NL4-3, were apoptotic. The nef, vpr, and vpu gene products were not responsible for
apoptosis of NL4-3-infected cells, since NL4-3DVprDVpuDNef and HXB-2 (a nef, vpr, and vpu triple mutant derived from IIIB)
also killed infected cells. Moreover, only IIIB-infected cells showed a resistance to background levels of apoptosis. Thus, the
apoptotic (and antiapoptotic) properties of HIV-1 do not map solely to mutations in nef, vpr, or vpu. We postulate that, in vivo,
HIV variants that do not induce rapid apoptosis in the cells they infect may have a selective advantage. © 1998 Academic Press
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INTRODUCTION
An understanding of how T cells die in HIV-1 infection
is of critical importance for eradication of the virus (Fauci,
1993). Dogma holds that HIV-1 kills the T cells that it
infects, although the mechanism(s) of this killing remain
obscure and controversial. Recent studies of viral dy-
namics have been interpreted to mean that infected cells
die at a rapid rate (Ho et al., 1995; Wei et al., 1995). These
data have been challenged on a number of fronts, in-
cluding by studies of T cell turnover, redistribution, and
telomere length (Hellerstein and McCune, 1997; Roe-
derer, 1998) and by direct analyses of cell death in
infected tissues (Finkel et al., 1995; and A. Haase, per-
sonal communication). Finally, the work of Siliciano and
co-workers (Finzi et al., 1997) showing the persistence of
T cells harboring infectious virus, even after prolonged
therapy with highly active antiretroviral drugs, argues
that productive infection does not kill all infected cells.
Many studies have proposed that apoptosis is a major
pathogenic mechanism of immune dysfunction in HIV
infection (Ameisen, 1994). Increased apoptosis of im-
mune cells from lymph nodes and peripheral blood
mononuclear cells (PBMC), including CD41 and CD81 T
cells, has been shown in HIV-infected individuals and is
enhanced by activation (Carbonari et al., 1995; Cotton et
al., 1997; Finkel et al., 1995; Groux et al., 1992; Meyaard
et al., 1992; Muro-Cacho et al., 1995; Oyaizu et al., 1993).
In animal models of HIV disease, increased apoptosis is
seen in rhesus macaques, which develop simian AIDS,
but not in infected chimpanzees, which rarely become
immunodeficient (Estaquier et al., 1994; Gougeon et al.,
1993, 1997).
Data assessing cell death in in vitro infection have
been confounded by the failure to discriminate infected
from uninfected cells (Ameisen, 1994; Levy, 1993). Re-
cently, several groups have analyzed apoptosis in in-
fected versus uninfected T cells and have concluded that
death occurs in the infected subset (Gandhi et al., 1998;
Herbein et al., 1998; Noraz et al., 1997). These assays
were, however, based on a limited sampling of HIV-1
isolates and, in some reports, the methods of “ tagging”
the infected cells rendered the viruses mutant by re-
moval of an auxiliary gene or by increased genome
length after insertion of a reporter gene.
To address the question of whether increased apopto-
sis is due to direct killing of infected cells or of unin-
fected bystander cells, we exploited a system of single-
cell analysis in HIV-1-infected cultures to simultaneously
identify apoptotic and infected cells. In this study, we
present the first evidence that some HIV-1 strains do not
kill productively infected T cells. Of even more impor-
tance, we present evidence that some HIV-1 strains may
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actually protect infected cells from the baseline levels of
apoptosis seen in in vitro culture. This paper also pro-
vides the first mapping data of apoptosis inhibition in
HIV-1-infected cells, showing that the accessory genes
nef, vpr, and vpu are not the critical determinants. Con-
sistent with recent reports, we find that viruses with open
reading frames in all genes or deleted in nef, vpr, and vpu
directly kill infected cells (Gandhi et al., 1998; Herbein et
al., 1998).
RESULTS AND DISCUSSION
The CD41 CEM T cell line and activated human PBMC
were infected with different HIV-1 strains. Productive
FIG. 1. Dual analysis for HIV infection and apoptosis. (A) CEM cells were mock infected or infected with HIV-1 IIIB at an m.o.i. of 0.05. Samples were
analyzed by two-color flow cytometry for p24gag expression and TUNEL at day 14 postinfection. Apoptotic analysis by TUNEL and morphologic
changes in scatter are gated through the corresponding uninfected and infected cell populations indicated by arrows. For TUNEL, a parallel sample
without TdT in the reaction mix was used to set a marker for positivity. Mock-infected cells treated with 10 mM beauvericin for 16 h served as a positive
control (data not shown). The region drawn in the scatter plot represents apoptotic cells with decreased forward and increased side scatter. This
region was determined by incubating mock-infected control cells for 16 h after exposure to g-irradiation (500 rads, data not shown). The numbers
shown in each scatter plot correspond to the percentages of cells present within this region. These results are representative of five independent
experiments analyzing apoptosis by TUNEL, propidium iodide staining, annexin V assay, or scatter changes. (B) Mouse T cells (Ms262), with or
without transfected human CD4, were labeled with CSFE and cocultured with equal numbers of HIV-1 IIIB-infected CEM cells. After 36 h in culture,
samples were stained with anti-p24gag mAb. Shaded, thin-lined histograms represent IIIB-infected CEM cells in the coculture. Open, thick-lined
histograms represent CSFE-labeled mouse cells in the coculture. For comparison, CSFE-labeled mouse cells without coculture are shown as open,
thin-lined histograms. The marker indicates the defined boundary for p24gag positivity in experiments with CEM cells. These results are representative
of two independent experiments. (C) In situ hybridization with HIV antisense RNA probe and in situ nick translation for apoptosis were performed on
HIV-1 IIIB-infected CEM cells at day 12 postinfection. Artificial tissue blocks were prepared as described under Materials and Methods. Microscopic
analyses were performed using epipolarized-xenon illumination. HIV hybridization signals are labeled by blue grains and apoptotic nuclei appear red.
Two controls for nonspecific background were used: mock-infected tissue blocks were stained in parallel and adjacent sections of the IIIB-infected
tissue blocks were hybridized with HIV sense RNA probe and TUNEL minus TdT in the reaction (data not shown). Objective magnification is 403.
These results are representative of two independent experiments.
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infection was followed by immunostaining for HIV capsid
protein p24gag. Cell death was concurrently assessed by
at least two of the following independent measures:
TUNEL,3 propidium iodide DNA staining, morphologic
changes in scatter, and annexin V binding. TUNEL iden-
tified cells with fragmented DNA, a defining end point of
apoptosis. The use of the intercalative dye propidium
iodide permitted detection of cells with hypodiploid DNA
content, considered apoptotic due to the loss of frag-
mented DNA. Changes in scatter identified cells with
diminished forward scatter and increased side scatter,
reflecting the earlier morphologic changes of apoptosis
of decreased cell size and increased granularity, respec-
tively. Finally, annexin V staining permitted detection of
early phase apoptosis, namely, phosphatidylserine (PS)
exposed on the outer cell membrane.
Cells infected with the HIV-1 strain IIIB were harvested
at 2- to 4-day intervals postinfection and analyzed flow
cytometrically for infection and apoptosis. As seen in Fig.
1A, two populations of cells were identified by p24gag
immunostaining and were defined as p24gag negative
and p24gag positive, corresponding to infected and unin-
fected cells, respectively (see below). Simultaneous
analysis of apoptosis within these two populations was
performed to address whether infected or uninfected
cells were dying. Cells expressing p24gag contained only
small numbers of apoptotic cells (1–7%, Fig. 1A). In con-
trast, the p24gag-negative population exhibited large
numbers of apoptotic cells (28–42%, Fig. 1A), measured
by TUNEL and morphologic change. These results show
substantial numbers of uninfected cells dying relative to
infected cells. This finding mimics the recent observa-
3 Abbreviations used: TUNEL, TdT-mediated dUTP nick end labeling;
CSFE, 5-(and-6)carboxyfluorescein diacetate, succinimidyl ester.
FIG. 1—Continued
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tions in HIV-infected individuals that the number of CD41
(and CD81) cells lost during disease progression ap-
pears greater than the number of infected cells (Goro-
chov et al., 1998; Pakker et al., 1998). Thus, decline in T
cells cannot be a sole consequence of direct viral cytol-
ysis. The role of long-lived productively infected cells
needs to be considered as a key player in the induction
of apoptosis in bystander immune cells.
Of concern in defining the cultured cells shown in Fig.
1A as infected was the fact that both peaks of p24gag
immunostaining were greater in intensity than the iso-
type-matched control antibody (data not shown) and the
anti-p24gag stain of mock-infected CEM cells (Fig. 1A). It
is possible that cells staining in this intermediate posi-
tion relative to negative and highly positive stains are, in
fact, uninfected cells. To address this possibility, exper-
iments were performed using the fluorescent cytoplas-
mic dye CSFE. CSFE covalently stains intracellular mac-
romolecules without interfering with cell function
(Weston and Parish, 1990) and is easily identified flow
cytometrically. Uninfected CEM cells were tagged with
CSFE, mixed with HIV-1 IIIB-infected cells, and then an-
alyzed immediately for p24gag expression. The CSFE-
labeled cells in the HIV-1 coculture were located solely
at the intermediate position (data not shown). It was
unlikely that this was due to low-level infection since
identical experiments with uninfectable mouse T cell
lines, with or without transfected human CD4, also ap-
peared at the intermediate position after coculture for
36 h with infected cells (Fig. 1B). These data confirm and
extend earlier results of Cory et al. (1987) and Heynen
and Holzer (1992). Cells in the intermediate region are
probably uninfected or latently infected cells which,
when permeabilized in the presence of highly infected
cells, increase in fluorescence beyond the negative
range due to association with leached viral antigen.
Therefore, these two populations were defined as p24gag
negative and p24gag positive, corresponding to unin-
fected and infected cells, respectively.
To confirm our analyses of apoptosis and p24gag ex-
pression, we performed concurrent measurement of
apoptosis and HIV-1 RNA expression using in situ label-
ing techniques (Fig. 1C). Viral RNA, indicative of produc-
tive infection, was detected by in situ hybridization (ISH)
of riboprobes complementary to greater than 90% of the
HIV-1 genome. Apoptosis was detected by in situ nick
translation. Examination was performed on 100 fields,
each measuring 200 mm in diameter, with a total of
;1200 cells. Sections examined by epifluorescent mi-
croscopy displayed apoptosis occurring predominantly
in bystander cells and not in productively infected cells.
In previous work (Finkel et al., 1995), our ability to detect
actin mRNA in cells undergoing apoptosis and the sim-
ilar work of Goebel et al. (1992) demonstrating detection
of vesicular stomatitis virus RNA in apoptotic cells sug-
gest that if HIV RNA were present in apoptotic cells it
would also be detected. Although the frequency of
apoptotic infected cells, as seen in Fig. 1C, was rare,
their occurrence reaffirms detection of HIV RNA during
apoptosis. This evidence confirms our flow cytometric
data that productive infection with HIV is not sufficient to
induce apoptotic cell death and that the majority of ap-
optosis in the IIIB-infected culture is observed in unin-
fected, bystander cells.
To extend our analyses of apoptosis and infection
using other viral isolates, experiments were performed
using the molecular clone NL4-3, which has open read-
ing frames in all genes (Adachi et al., 1986). The low
number of productively infected, apoptotic cells was a
characteristic of the IIIB virus, since many p24gag-posi-
tive apoptotic cells were observed in the NL4-3 infection
(Fig. 2A). This difference could not be attributed to an
effect of infection level because both cultures contained
similar levels of HIV-expressing cells; in fact, IIIB was
higher (38%) compared with NL4-3 (26%). As shown in
the time course in Fig. 2B, levels of apoptosis in produc-
tively infected p24gag-positive cells from NL4-3 cultures
were greater than or equal to levels of apoptosis in
p24gag-negative cells within the same culture. Analysis of
apoptosis in infected NL4-3 cells was not performed
after day 30 postinfection due to cessation of virus ex-
pression. Surprisingly, IIIB-infected cells exhibited a pro-
FIG. 1—Continued
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tective effect on cell viability by inhibiting apoptosis to
less than that of mock-infected background levels, sug-
gesting that differences in the viral genetic make-up may
exist which prevent death of the infected cells. Indeed,
recent reports that HIV encodes genes which protect the
infected cells from apoptosis support this hypothesis
(Finkel and Casella, 1998). Tat, Nef, and capsid protein
(CA) may block critical steps in apoptotic pathways.
Similar mechanisms have been shown to operate in
other viral infections, such as Epstein–Barr and adeno-
virus. In addition, viral genes, i.e., vpr, may alter suscep-
tibility to apoptosis by affecting activation status through
alteration of the cell cycle (Goh et al., 1998; He et al.,
1995; Stewart et al., 1997) or by inhibition of NFkB
(Ayyavoo et al., 1997). Combinations of these potentially
antiapoptotic genes, with or without mutations, and/or
other candidate genes may explain the ability of IIIB-
infected cells to avoid being killed.
No significant difference was measured among the
various methods of detection for apoptosis in the unin-
fected or infected CEM cells (P . 0.12 for both popula-
tions). In addition, no significant difference was mea-
sured in apoptosis of uninfected or infected CEM cells at
various time points postinfection (P . 0.12 for both pop-
ulations). Therefore, apoptosis data from all methods of
detection and all time points were combined for analysis.
Aggregate data showed significant levels of apoptosis
above mock-infected cultures in the p24gag-negative
cells of the IIIB culture and in both populations (p24gag
positive and negative) of cells in the NL4-3-infected cul-
ture (P , 0.003 for each population, Figs. 3A and 3B). In
contrast, the IIIB productively infected p24gag-positive
cells displayed a trend toward levels of apoptosis below
those of corresponding mock-infected control cultures
(Fig. 3A). The p24gag-positive cells in the IIIB and NL4-3
cultures were significantly different from each other with
respect to measured apoptosis (P , 0.0002), while the
p24gag-negative cells were not (P 5 0.73). Also, no dif-
ference was seen between NL4-3 and a DNef NL4-3
mutant (data not shown). Consequently, the nef gene
product is not responsible for apoptosis of the NL4-3-
infected cells.
The effect of HIV-1-induced apoptosis in PBMC was
examined in order to confirm the results obtained in CEM
cells in a primary cell type. Activated PBMC from sero-
negative donors were infected with different HIV-1
strains and monitored for infection and apoptosis. Six
different donors were used in independent experiments
to reduce individual variability in response to infection.
As shown in Fig. 4A, two principal populations of cells
were manifest by p24gag staining in PBMC, as previously
described (Heynen and Holzer, 1992; Ohlsson-Wilhelm et
al., 1990). The p24gag-negative region in the HIV-infected
cultures was superimposable upon the mock-infected
p24gag-negative and the isotype control regions. Thus,
this staining profile allowed a clear discrimination be-
tween HIV-positive and -negative phenotypes. Concom-
itant staining for annexin V within the subsets (based on
p24gag positivity) revealed greater numbers of apoptotic
cells in the uninfected (6.8%) versus the infected (2.6%)
populations in the IIIB culture. The opposite relationship
was observed in the NL4-3 culture, with greater apopto-
sis in the infected than the uninfected cells; 16.2%
apoptotic infected cells compared with 10.4% apoptotic
uninfected cells. The uninfected cells in both the IIIB and
NL4-3 cultures showed greater apoptosis than the mock-
infected cultures. Interestingly, only the IIIB-infected cells
demonstrated less apoptosis than background (mock
infected 5 3.7%). These data corroborate the prior ob-
servations in the CEM cell line. The predominant popu-
lation dying during HIV-1 IIIB infection is uninfected.
Conversely, in the NL4-3 culture, while a significant level
of apoptosis is seen in the uninfected cells, the majority
of death is due to direct infection.
Time-course analysis of HIV infection in PBMC (Fig.
4B) showed virus expression peaking between days 3
and 7 postinfection. Apoptosis in the NL4-3-infected cells
increased rapidly over time and was higher than follow-
ing mock infection at all time points and all m.o.i.s tested
(Fig. 4C). Analysis of apoptosis for NL4-3-infected cells
was not performed at time points after day 7 due to lack
of detectable virus. IIIB-infected cells displayed apopto-
sis levels similar to or less than those of mock-infected
cells at all time points and all m.o.i.s tested (Fig. 4C). In
contrast to the dramatic difference seen between the
infected cells, the uninfected cells in the IIIB and NL4-3
cultures displayed similar levels of apoptosis (4–10%) at
an approximately steady level above mock-infected con-
trols (Fig. 4D).
No significant difference was measured among the
various methods of detection for apoptosis in the unin-
fected or infected PBMC (P . 0.37 for both populations).
Thus, all methods of detection for apoptosis were com-
bined for analysis. In addition, no significant difference
was measured in apoptosis of uninfected PBMC at var-
ious time points postinfection (P 5 0.56). A significant
difference was measured in apoptosis of infected PBMC
at sampled time points postinfection, with apoptosis in
infected cells increasing over time (P 5 0.001). However,
since this effect of increased apoptosis over time was
similar in all viruses, the apoptosis data were pooled
across time. When data from all PBMC experiments were
combined, apoptosis in the NL4-3-infected cells was
significantly higher than in mock-infected cells (P 5
0.0014, Fig. 5A). In contrast, IIIB-infected cells displayed
apoptosis levels below mock-infected cells (P 5 0.15).
Aggregate data for uninfected PBMC showed equally
significant levels of apoptosis above mock-infected cells
for NL4-3 and IIIB (P 5 0.0053 and P 5 0.02, respectively,
Fig. 5B).
To map the gene(s) responsible for the difference in
levels of apoptosis detected in infected cells from the IIIB
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and NL4-3 cultures, genetically defined mutant clones of
HIV were studied. Two clones with mutations in the
accessory genes vpr, vpu, and nef were used to infect
PBMC. HXB-2 is derived from the parent strain IIIB and
DRDUDN is a laboratory-designed triple mutant created
in NL4-3. There was no significant difference observed
between the HXB-2 and DRDUDN mutants and the NL4-3
virus with respect to infected (P . 0.50, Fig. 5A) or
uninfected cell death (P . 0.55, Fig. 5B). A significant
difference in the infected cells was observed, however,
between the NL4-3 virus and IIIB (P , 0.05, Fig. 5A).
Notably, only the IIIB-infected cells showed less apopto-
sis than the mock-infected culture.
In summary, all virus infections caused significant ap-
optosis of uninfected cells. Death of infected cells de-
pended on the viral strain used. NL4-3, HXB-2, and
DRDUDN viruses showed equally significant killing of the
infected cells, indicating that the death seen in the NL4-
3-infected cells is not solely attributable to vpr, vpu, or
nef. Infection with IIIB, however, did not cause significant
death of the infected cells. Indeed, IIIB-infected cells
appeared to be slightly protected from apoptosis. The
inability of IIIB to kill infected cells cannot be attributed to
lower infection level, since p24gag expression was equal
to or greater than NL4-3 in most experiments. Moreover,
IIIB-infected cells continued to express virus at higher
levels longer than NL4-3 (see Figs. 4C and, especially,
2C). The protective factor demonstrated in the IIIB-in-
fected cells cannot be easily identified based on the
results obtained using HXB-2, a molecular clone derived
from the IIIB strain. Cloning of IIIB with subsequent
mapping and sequence analysis may elucidate the pro-
tective factor. Our data are most consistent with a model
novel to our understanding of HIV-1 biology, although
reminiscent of the biology of many other viruses. Our
data suggest that HIV-1 encodes both proapoptotic and
antiapoptotic genes. We propose that it is the balance of
these genes that determines the fate of the infected
cells. This balance may be altered by viral load, by viral
mutation, or by the cellular environment.
MATERIALS AND METHODS
Cell culture.The lymphoblastoid CD41 T cell line
CEM-SS was obtained from the repository of the NIH
AIDS Research and Reference Reagent Program (from
FIG. 2. Comparison of HIV-1-induced apoptosis between IIIB and NL4-3 in CEM cells. (A) CEM cells were mock infected or infected with IIIB or
NL4-3 at an m.o.i. of 0.05. After 8 days, samples were concomitantly stained with anti-p24gag and propidium iodide. The DNA fluorescence histograms
of propidium iodide staining are gated through the corresponding uninfected and infected cell populations indicated by arrows. The numbers in the
DNA histograms show the percentages of apoptotic cells. Identification of apoptotic cells with hypodiploid (sub Go/G1) DNA content was based on
mock-infected controls incubated with 10 mM beauvericin for 16 h (data not shown). (B) CEM cells were infected as described for A and kinetics of
infection were monitored flow cytometrically by staining for p24gag expression on the indicated days after infection. (C and D) Simultaneous staining
of p24gag with propidium iodide was performed to identify apoptotic cells. The time course for apoptosis in the (C) infected and (D) uninfected cells
in the culture was measured by gating on the specific populations identified by the p24gag stain, as shown in A. Death in the mock-infected culture
is shown in C and D for reference. These results are representative of five independent experiments analyzing apoptosis by TUNEL, propidium iodide
staining, annexin V assay, or scatter changes.
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Peter L. Nara). The mouse T cell line Ms262 (Wegener et
al., 1992) and the human CD4 expressing line
hCD4Ms262, generated by transforming Ms262 with the
human CD4 retroviral expression vector pMV6tk/neo
(Maddon et al., 1985), were kind gifts of Dr. W. Jensen.
Human PBMC were isolated from healthy HIV-seroneg-
ative donors by Ficoll–Paque separation (Pharmacia Bio-
tech AB, Uppsala, Sweden). All cells were maintained in
RPMI 1640 medium (Gibco-BRL, Gaithersburg, MD) sup-
plemented with 10% fetal calf serum (FCS), 2 mM L-
glutamine, 100 U/ml penicillin G, and 100 mg/ml strepto-
mycin. PBMC were incubated for 3 days with 2.5 mg/ml
phytohemagglutinin (PHA; Murex, Research Triangle
Park, NC) before the addition of 10 U/ml human recom-
binant interleukin-2 (hrIL-2; R & D System, Minneapolis,
MN). For intracellular labeling, cells were incubated with
3 mM 5-(and-6-)carboxyfluorescein diacetate (CSFE; Mo-
lecular Probes, Eugene, OR) for 5 min at room tempera-
FIG. 3. Percentages of infected and uninfected apoptotic cells in
CEM. Percentage apoptosis in (A) infected and (B) uninfected cells.
Apoptosis data from all methods of detection and all time points were
combined for analysis. Apoptosis in experimentally matched mock-
infected controls was subtracted from apoptosis measured in virus
samples at each time point. The diamonds represent descriptive sta-
tistics for each virus. The upper and lower vertices are the 95% confi-
dence limits around the mean, based on a pooled variance estimate.
The horizontal lines nearest the vertices are overlap markers that
indicate which means are different from each other. The horizontal line
through the center of the diamond is the mean and the vertical target
line represents one standard error around that mean. A horizontal
reference line at 0% is shown. A 95% confidence interval that includes
the 0% reference line is not different from mock infected.
FIG. 2—Continued
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ture in RPMI 1640 medium without FCS and then washed
twice in PBS. To induce apoptosis in vitro, the ionophore
beauvericin (Sigma Chemical Co., St. Louis, MO) was
resuspended in EtOH at a stock concentration of 1
mM and used in tissue culture at a final concentration of
1–10 mM.
Viruses. The HIV molecular clone NL4-3 (Adachi et al.,
1986) was obtained from Dr. Ronald Desrosiers through
the NIH AIDS Research and Reference Reagent Program
and was supplied as 59 and 39 halves. Construction of
the DRDUDN clone containing mutations in nef, vpr, and
vpu in the NL4-3 backbone was described previously
(Mustafa and Robinson, 1993). HIV-1 strain IIIB (ABI,
Columbia, MD) was passaged in CEM cells. Clone
HXB-2 (Fisher et al., 1985), derived from the parental
virus IIIB, defective for three nonessential auxiliary
genes (nef, vpr, and vpu), was kindly provided by Dr. D.
Looney. Virus stocks of molecular clones were produced
by transfecting 293 cells with 3 mg of DNA and harvest-
ing the supernatant at 48 h. This supernatant was then
used to infect CEM cells and the supernatant was har-
vested at days 4–8. All HIV stocks were titered using
CD4-LTR/b-gal indicator cells (Kimpton and Emerman,
1992) and stored at 270°C.
Infections. Infection was accomplished by incubating
1–5 3 106 target cells at different multiplicities of infec-
tion for 2 h at 37°C in 5% CO2 and then washing once
with RPMI 1640. Mock infections were performed under
the same conditions, except that the supernatant was
generated from uninfected cells. The cultures were
counted and split every 2–3 days to maintain concentra-
tions of 1–10 3 105 and 1–3 3 106 cells/ml for CEM and
PBMC, respectively.
Flow cytometry and detection of apoptosis. Cells (1–
2 3 106) were harvested and fixed in 1% paraformalde-
hyde for 30 min at room temperature. After fixation, sam-
ples were washed once in PBS. HIV-infected cells were
identified by staining for expression of intracytoplasmic
p24gag. Cells were permeabilized in 0.1% saponin (Sig-
ma) and 10% FCS in PBS for 10 min at room temperature
and then stained in the same buffer with 2.5 ml of PE-
conjugated anti-p24gag mAb (KC57-RD1; Coulter, Hi-
aleah, FL) for 30 min at room temperature. All samples
were also stained in tandem with an isotype-matched
control Ab (MsIgG1-RD1; Coulter). Four methods were
employed to identify apoptosis. First, the annexin assay
was performed, prior to cell fixation, according to the
manufacturer’s instructions (Caltag Labs, Burlingame,
FIG. 4. Comparison of HIV-1-induced apoptosis between IIIB and NL4-3 in activated PBMC. (A) PBMC were isolated from seronegative donors and
activated with PHA and IL-2 before being mock infected or infected with IIIB or NL4-3 at an m.o.i. of 0.05. Samples were harvested and stained with
anti-p24gag mAb and annexin V at day 4 postinfection. Analysis of the annexin V assay was gated through the uninfected and infected cell populations
indicated by arrows. The numbers shown in the annexin V histograms represent the percentages of cells with exposed phosphatidylserine, indicative
of apoptosis. As a positive control, mock-infected cells were exposed to g-irradiation (500 rads) for 16 h and stained in tandem (data not shown). (B)
PBMC were infected as described for A, except various m.o.i.s, as indicated for B, were used. Mock infection was done using the largest m.o.i. volume,
0.12. Kinetics of infection were monitored flow cytometrically by staining for p24gag expression on the indicated days after infection. (C and D) Analysis
for apoptosis in the (C) infected and (D) uninfected populations in each culture is the same as described in the legends to Figs. 2C and 2D. These
results are representative of seven independent experiments analyzing apoptosis by TUNEL, propidium iodide staining, annexin V assay, or scatter
changes.
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CA). Briefly, cell samples (1 3 106) were harvested,
washed once in PBS, and resuspended in 100 ml Binding
Buffer containing 2.5 mM CaCl2 and 5 ml annexin V–FITC.
Samples were incubated for 20 min at room temperature,
washed once in Binding Buffer, and then fixed. All sub-
sequent steps with annexin-stained samples were sup-
plemented with 2.5 mM CaCl2. Second, after fixation but
prior to staining for p24gag, the terminal deoxynucleotidyl
transferase nick end-labeling (TUNEL) assay was used
to detect ladder-like internucleosomal DNA fragmenta-
tion (Li et al., 1995; Meyaard et al., 1992). Cells were
permeabilized in 70% EtOH, washed twice in PBS, and
incubated for 1 h at 37°C in a final volume of 50 ml, with
3 mM fluorescein–12-dUTP, 5 U terminal deoxynucleoti-
dyl transferase (TdT), 12.5 mM deoxynucleotide mix, 1.5
mM CoCl2, 200 mM potassium cacodylate, 25 mM Tris–
HCl, pH 7.4, and 250 mg/ml BSA (all from Boehringer-
Mannheim, Indianapolis, IN). Control samples without
TdT were included. Third, after staining for p24gag, cells
with hypodiploid (sub G0/G1) DNA content were detected
according to published methods (Darzynkiewicz et al.,
1992; Telford et al., 1992). Samples were centrifuged and
FIG. 5. Percentages of infected and uninfected apoptotic cells in
PBMC. Percentage apoptosis in (A) infected and (B) uninfected cells.
Apoptosis data from all methods of detection and all time points were
combined for analysis. Apoptosis in experimentally matched mock-
infected controls was subtracted from apoptosis measured in virus
samples at each time point. The descriptive statistics are the same as
detailed in the legend to Fig. 3.
FIG. 4—Continued
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resuspended in PBS containing 5 mg/ml propidium io-
dide, 5 mM EDTA, 0.1% saponin, and 50 mg/ml RNase A
(all from Sigma). Fourth, apoptotic cells exhibit morpho-
logical changes which are readily detected flow cyto-
metrically according to their light-scatter properties (Car-
bonari et al., 1995; Cotton et al., 1997; Gougeon et al.,
1997). Phenotyping of apoptotic cell shrinkage and in-
creased granularity was analyzed by following reduced
FSC and increased SSC, respectively. After washing
twice in PBS, all samples were analyzed within 24 h on
a FACScan (Becton–Dickinson, San Jose, CA) flow cy-
tometer. Data were collected and analyzed with
Cellquest and Cell Lysis software (Becton–Dickinson).
In situ hybridization. Artificial tissue blocks were pre-
pared from cultured cells by resuspending 1 3 106 cells
in 1 ml of plasma from a HIV-1-seronegative donor and
immediately adding 250 ml of 5 mg thrombin (Sigma)
dissolved in H2O. Clots formed within 10 min and 10 ml
of 4% paraformaldehyde was added. The clot was then
sectioned after paraffin embedding to allow examination
in an inert medium. In situ TUNEL and RNA hybridization
with probes covering 90% of the HIV-1 genome were
performed as previously described (Finkel et al., 1995).
Sections were analyzed with epipolarized-xenon illumi-
nation, using a Peltier cooled charge-coupled device
(CCD; SpectraSource Institute, Westlake Village, CA)
mounted on a Zeiss Axiophot microscope (Zeiss, Thorn-
wood, NY), and processed with IPLab Spectrum software
(Scanaltics Inc., Fairfax, VA).
Statistics. Percentages of apoptotic cells were ana-
lyzed after averaging across two or three replicates and
subtracting the corresponding percentage from a mock-
infected control condition run in the same experiment.
Results were summarized using the mock-adjusted
mean and standard error within conditions. Individual
mean percentages were compared to mock using one-
sample t tests and 95% confidence intervals. Mock-ad-
justed percentages were compared between conditions
using analysis of variance. Multiple comparisons be-
tween more than two conditions were performed using
Tukey’s honestly significant difference procedure. All
tests were performed at the 0.05 level of significance. All
analyses were performed using JMP software, version
3.2.2 (SAS Institute, Cary, NC).
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